Wilex acquires cancer diagnostics assets from Siemens; gains US access
This article was originally published in Clinica
Executive Summary
German biopharmaceutical company Wilex has acquired the assets of Oncogene Science, a unit of Siemens Healthcare Diagnostics specialising in gene-based cancer ELISA assays.